Website: https://www.api.polpharma.com/
Industry: Active Pharmaceutical Ingredients (APIs), CDMO Services, Small‑Molecule Development & Manufacturing

1. Company Overview
Polpharma API is a European CDMO and API manufacturer with over 70–75 years of experience, providing high‑quality small‑molecule APIs supported by cGMP‑compliant and FDA‑approved manufacturing facilities in Central Europe.
The company supports both emerging and established pharmaceutical customers in process development, scale‑up, technology transfer, and commercialization. [api.polpharma.com], [api.polpharma.com]

2. Key Capabilities & Services
CDMO Services

End‑to‑end API development, from early clinical stages to commercial supply.
Expertise in complex chemical processes, including cryogenic reactions, high‑pressure reactions, hazardous chemistry, micronization, crystallization, and more. [cdn.prod.w...-files.com]
Phase‑appropriate method development, cGMP batches, validation, and scale‑up.
Strong regulatory support, including documentation aligned with EDQM (CEP), ICH (EU DMF, CTD), FDA (US DMF). [test.api.p...pharma.com]

API Manufacturing

Fully vertically integrated from R&D to commercial scale.
FDA‑approved and cGMP‑compliant multipurpose plant.
Production ranging from kilograms to multi‑ton commercial quantities. [test.api.p...pharma.com]


3. Technologies & Special Competencies
High Potency APIs (HPAPI)

High‑potent GMP capabilities up to OEB ≤ 6.
Engineering controls for safe containment and large‑scale operation. [cdn.prod.w...-files.com]

Cryogenic Technology

Reactor ranges from 0.1–0.5 m³.
Operational temperatures as low as –80°C. [cdn.prod.w...-files.com]

Oligonucleotide Manufacturing

Commercial reactors 2.5–6.3 m³; total reactor volume 23.5 m³.
End‑to‑end process: solid‑phase synthesis → purification → lyophilization → packaging. [cdn.prod.w...-files.com]

Additional Capabilities

Micronization
Hydrogenation
Tailor‑made PSD control
Impurity profiling (genotoxic, nitrosamines, unknowns)
 [cdn.prod.w...-files.com]


4. Product Portfolio
Therapeutic Categories
Products cover a wide range of therapeutic areas:

Blood Forming
Cardiology
Diabetics
Erectile
Fungal
Musculo‑skeletal
Neurology
Oncology
Oligonucleotides
 [api.polpharma.com]

Examples of APIs (Commercial or Pipeline)

Dapagliflozin & Dapagliflozin Propanediol Monohydrate
Vardenafil HCl
Rivaroxaban
Empagliflozin
Enzalutamide
Safinamide methanesulfonate
Ticagrelor
Abemaciclib
 [api.polpharma.com]

Polpharma manufactures API quantities from clinical supply to full commercial scale, with extensive documentation available (DMF, CEP, CADIFA depending on product). [cdn.prod.w...-files.com]

5. Quality & Compliance

Facilities undergo rigorous FDA inspections, all successfully passed.
Testing aligned with European and United States Pharmacopeias.
Quality-first culture reflected across manufacturing, technology transfer, and customer interactions.
 [test.api.p...pharma.com]


6. Global Reach

Over 70 markets globally.
Presence across six continents.
Broad experience with restrictive markets (EU5, USA, Japan, Korea).
 [api.polpharma.com]


7. Organizational Strength

Approximately 450 employees across two European manufacturing sites.
Strong R&D teams: ~30 process development specialists, ~40 additional technical experts.
Fully integrated business unit for fast decision‑making and efficient customer support.
 [api.polpharma.com], [cdn.prod.w...-files.com]


8. Cooperation Models
Polpharma API offers flexible partnership frameworks:

CDMO (full lifecycle service)
Supply of Polpharma‑developed APIs
Co‑development partnerships
Contract Manufacturing (CMO)
 [api.polpharma.com]


9. Mission & Positioning
Polpharma API positions itself as:

A reliable European CDMO partner.
Focused on innovation, regulatory excellence, and customer satisfaction.
Delivering high‑quality, safe, compliant, and environmentally responsible API manufacturing solutions.